Article

The Benefits of Personal Training

Author(s):

Exercise and nutrition intervention for patients with cancer could help with symptoms from treatment.

As director of Rocky Mountain Cancer Rehabilitation Institute at the University of Northern Colorado in Greeley, Colo., part of Reid Hayward’s mission is to investigate exercise and nutrition as an intervention for symptoms related to cancer treatment.

Hayward and his students offer one-on-one coaching three days a week at the cancer center, he says. Think of them as cancer personal trainers. “Once we get the patients in here,” Hayward continues, “they’re hooked.”

“Other centers give them a handout. We give them an initial assessment of balance, strength and endurance, and then reassess every three months.”

He witnesses the benefits of working out during and after treatment, but he’s not surprised that patients aren’t lining up at the door before treatment starts. Most “are overwhelmed by too many other things with a higher priority.”

So, when he doesn’t have enough trial participants, he and his team work with rats to study aerobic conditioning and the effects of chemotherapy.

It’s difficult to apply lessons learned in animal trials directly to humans, although many physicians recommend light exercise to reduce certain treatment-related effects, such as fatigue and depression. Hayward is convinced that “the protective effect of exercise” can have a lasting impact. He suggests—only half-kiddingly—that patients receiving chemotherapy might be well served to “jog to treatment.”

Related Videos
Image of Dr. Fakih.
.Dr. Catherine Wu, chief of the Division of Stem Cell Transplantation and Cellular Therapies at Dana-Farber Cancer Institute, and institute member at the Broad Institute of MIT and Harvard, in Boston
Image of Doctor with blonde hair.
Dr. Katy Beckermann discusses how a Fotivda and Opdivo combination for renal cell carcinoma compared with Fotivda alone based on patient feedback.
Dr. Petros Grivas discusses what precautions should be considered when treating patients with advanced urothelial carcinoma who have diabetes.
Dr. Debu Tripathy discussed the importance of understanding the distinctions between HER2-low and HER2-ultralow breast cancer.
Primary urothelial cancer has variable histologies, making its treatment complex, leading to varied outcomes with high rates of recurrence in patients.
Dr. Neeraj Agarwal is a medical oncologist, a professor of medicine and the Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute, University of Utah, as well as director of the Genitourinary Oncology Program and the Center of Investigational Therapeutics at the Huntsman Cancer Institute in Salt Lake City.
Image of Dr. Goy.
Image of bald man.
Related Content